Page last updated: 2024-11-04

homoserine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

homoserine : An alpha-amino acid that is glycine substituted at the alpha-position by a 2-hydroxyethyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

L-homoserine : The L-enantiomer of homoserine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12647
CHEMBL ID11722
CHEBI ID15699
SCHEMBL ID29649
MeSH IDM0010518

Synonyms (61)

Synonym
AC-5665
einecs 211-590-6
6ka95x0ivo ,
unii-6ka95x0ivo
nsc 206251
butyric acid, 2-amino-4-hydroxy-, l-
CHEBI:15699 ,
(2s)-2-amino-4-hydroxybutanoic acid
HSE ,
nsc-206251
672-15-1
C00263
l-homoserine
2-amino-4-hydroxybutyric acid
homoserine
DB04193
09EC5004-E0F7-4325-B392-59A264DAF51F
(2s)-2-ammonio-4-hydroxybutanoate
butanoic acid, 2-amino-4-hydroxy-, (s)-
homoserine (van)
butyric acid, 2-amino-4-hydroxy-, l- (8ci)
BMSE000040
isothreonine
CHEMBL11722
AKOS005146323
(s)-2-amino-4-hydroxybutyric acid
H1030
A835661
(s)-2-amino-4-hydroxybutanoic acid
(s)-homoserine
2-amino-4-hydroxybutyrate
AKOS016015443
h-hoser-oh
BP-13218
AM20100617
S3118
homoserine [mi]
s-2-amino-4-hydroxybutyric acid
l-2-amino-4-hydroxybutyric acid
homoserine, l-
SCHEMBL29649
mfcd00063090
h-hse-oh
STR06869
DTXSID5075159
l-homoserine,labeledwith carbon-14(9ci)
119736-88-8
CS-W002292
2-amino-4-hydroxy-l-butyrate
2-amino-4-hydroxy-butyrate
2-amino-4-hydroxy-butyric acid
(s)-2-amino-4-hydroxybutanoate
(s)-2-amino-4-hydroxy-butanoate
2-amino-4-hydroxy-l-butyric acid
(s)-2-amino-4-hydroxy-butanoic acid
HY-W002292
Q418214
EN300-75344
(s)-(-)-2-amino-4-hydroxybutyric acid
(s)-2-amino-4-hydroxybutyric acid, hse
Z1172369006

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" We investigated the basis for these other phenotypes and found that they are dependent on the toxic biosynthetic intermediate homoserine."( Homoserine toxicity in Saccharomyces cerevisiae and Candida albicans homoserine kinase (thr1Delta) mutants.
Kingsbury, JM; McCusker, JH, 2010
)
0.36

Compound-Compound Interactions

ExcerptReferenceRelevance
" In this study, strategies of engineering the synthetic pathway combined with regulating cell division were employed in an L-homoserine-producing Escherichia coli strain for efficiently biomanufacturing L-homoserine."( High-efficient production of L-homoserine in Escherichia coli through engineering synthetic pathway combined with regulating cell division.
Cai, M; Liu, Z; Rao, Z; Xu, M; You, J; Zhao, Z; Zhou, S, 2023
)
0.91

Dosage Studied

ExcerptRelevanceReference
" A thorough dose-response study using microdialysis in conscious rats indicated that low doses of ketamine (10, 20, and 30 mg/kg) increase glutamate outflow in the PFC, suggesting that at these doses ketamine may increase glutamatergic neurotransmission in the PFC at non-NMDA glutamate receptors."( Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.
Adams, B; Daly, D; Moghaddam, B; Verma, A, 1997
)
0.3
" In this study, we produced strains with multiple copies of the PDA1 CDC by protoplast fusion and analyzed dosage effects of this chromosome."( Duplication of a conditionally dispensable chromosome carrying pea pathogenicity (PEP) gene clusters in Nectria haematococca.
Garmaroodi, HS; Taga, M, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
algal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in algae including unicellular organisms like chlorella and diatoms to multicellular organisms like giant kelps and brown algae.
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
homoserineAn alpha-amino acid that is glycine substituted at the alpha-position by a 2-hydroxyethyl group.
amino acid zwitterionThe zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (24)

PathwayProteinsCompounds
Methionine Metabolism1637
Cystathionine beta-Synthase Deficiency1637
Hypermethioninemia1637
S-Adenosylhomocysteine (SAH) Hydrolase Deficiency1637
Glycine N-Methyltransferase Deficiency1637
Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)1637
Methionine Adenosyltransferase Deficiency1637
Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type1637
Methionine Biosynthesis1018
Threonine Biosynthesis1123
Secondary Metabolites: Threonine Biosynthesis from Aspartate715
Methionine Metabolism and Salvage1534
Threonine Metabolism619
methionine biosynthesis020
superpathway of lysine, threonine and methionine biosynthesis II032
isoleucine biosynthesis I024
superpathway of lysine, threonine and methionine biosynthesis I038
threonine biosynthesis016
methionine biosynthesis II018
methionine biosynthesis I017
AtMetExpress overview0109
Biochemical pathways: part I0466
Canavanine biosynthesis110
Homocysteine biosynthesis07
Homoserine biosynthesis010
Methionine biosynthesis II017
Threonine biosynthesis from homoserine07

Bioassays (2)

Assay IDTitleYearJournalArticle
AID407724Inhibition of Mycobacterium tuberculosis glutamine synthetase at 1 mM in water2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Evaluation of the amino acid binding site of Mycobacterium tuberculosis glutamine synthetase for drug discovery.
AID224504Effect on rate of GTP hydrolysis in the GTP binding protein ras p21; Not determined1998Bioorganic & medicinal chemistry letters, May-05, Volume: 8, Issue:9
Prediction of the GTPase activities by using the semiempirical molecular orbital theory.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,307)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990253 (19.36)18.7374
1990's101 (7.73)18.2507
2000's401 (30.68)29.6817
2010's437 (33.44)24.3611
2020's115 (8.80)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.08%)5.53%
Reviews83 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other1,245 (93.68%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]